BPC-157 / TB-500 Blend 20mg
$149.00
Two-peptide vial: BPC-157 10 mg and TB-500 10 mg, lyophilised together.
For laboratory research use only. Not for human or veterinary use. By ordering you confirm you are 18 or older and are purchasing for lawful research.
Availability: 24 in stock
- Content per vial
- 20 mg (10 mg + 10 mg)
- Vial
- 3 mL vial
- Form
- Lyophilised powder
- Unopened, long term
- −20 °C, protected from light
Bacteriostatic water for the lab
Research peptides are supplied as a lyophilised powder. Bacteriostatic water is the standard laboratory solvent for reconstituting them, and ours is independently tested. For laboratory research use only.
Description
A combined vial containing two research peptides. BPC-157 is a synthetic 15-amino-acid peptide whose sequence derives from a protein isolated from gastric juice. TB-500 is a synthetic peptide related to thymosin beta-4.
Nominal content is 10 mg of each peptide (20 mg total), supplied as lyophilised powder in a 3 mL vial.
Research background
BPC-157 is a synthetic 15-amino-acid peptide whose sequence derives from a protein found in gastric juice. Most published work on it comes from a single research group and has been carried out in rodent models, where it is studied in research on tissue repair, blood-vessel formation (angiogenesis) and the nitric oxide system.
TB-500 is a synthetic peptide based on the actin-binding region of thymosin beta-4 (Tβ4), a 43-amino-acid protein that is the main G-actin-sequestering peptide in most cells. Tβ4 is studied in research on the actin cytoskeleton and cell migration.
Research stage: Preclinical. There is very little published human data on BPC-157, and neither peptide is approved for therapeutic use. Both appear on the World Anti-Doping Agency prohibited list.
Selected published research
- Gwyer D, Wragg NM, Wilson SL. Cell Tissue Res. 2019;377(2):153-159. PubMed 30915550
- Sikiric P, Seiwerth S, Skrtic A, et al. Pharmaceuticals (Basel). 2025;18(6). PubMed 40573323
- Huff T, Müller CS, Otto AM, et al. Int J Biochem Cell Biol. 2001;33(3):205-220. PubMed 11311852
- Goldstein AL, Hannappel E, Sosne G, et al. Expert Opin Biol Ther. 2012;12(1):37-51. PubMed 22074294
This section summarises the subject of published research for reference only. It does not describe the effects of this product, which is supplied for laboratory research use only and is not for human or veterinary use.
Background reading: BPC-157 and TB-500: the two peptides in our 20 mg blend
Specifications
| Product | BPC-157 / TB-500 Blend 20mg |
|---|---|
| SKU | APX-BPTB-20 |
| Category | Peptide blends |
| Content per vial | 20 mg (10 mg + 10 mg) |
| Vial | 3 mL vial |
| Form | Lyophilised powder |
| Components | BPC-157 10 mg; TB-500 10 mg |
| BPC-157 sequence | Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val |
| BPC-157 molecular weight | 1419.5 g/mol |
| TB-500 | Synthetic peptide related to thymosin beta-4 |
| Intended use | Laboratory research only |
Storage
| Unopened, long term | −20 °C, protected from light |
|---|---|
| Unopened, short term | 2–8 °C for up to several weeks |
| After reconstitution | 2–8 °C; record the preparation date on the vial |
| Handling | Allow the vial to reach room temperature before opening to limit moisture uptake |
General guidance only. Follow your institution’s procedures for handling research materials.
Testing & COA
Third-party analysis by Janoshik Analytical. Details below are transcribed from the report; the PDF is the authoritative copy.
| Laboratory | Janoshik Analytical |
|---|---|
| Task number | #93610 |
| Sample as recorded | BPC157 10mg+TB500 10mg |
| Tests requested | Assessment of a peptide vial or vials. |
| Result: TB-500 (TB4) | 10.12 mg |
| Result: BPC-157 | 11.30 mg |
| Purity | Not reported for this test |
| Batch on report | Light green transparent cap |
| Sample received | 12 Dec 2025 |
| Analysis conducted | 15 Dec 2025 |
| Verification key | JWEF9BZILKG9 |
Janoshik report #93610PDFCommon questions
How much is actually in the vial?
Janoshik Analytical measured 10.12 mg TB-500 (TB4) and 11.30 mg BPC-157 in the vial it tested (report #93610, 15 Dec 2025). The label states 20 mg (10 mg + 10 mg). Measured amounts vary a little from batch to batch; the full results list everything the report covers.
How do I check the lab report is genuine?
Go to janoshik.com/verify and enter the key JWEF9BZILKG9. It brings up Janoshik's own record of test #93610, so you can confirm the PDF on this page matches what the laboratory issued.
What is it reconstituted with in the lab?
BPC-157 / TB-500 Blend 20mg is supplied as a dry, lyophilised powder. In the laboratory, lyophilised peptides are usually reconstituted with bacteriostatic water, the standard laboratory solvent, which we stock in 3mL and 10mL vials (for laboratory research use only). See the storage notes above for unopened and reconstituted vials.
How long does shipping take in Australia?
Orders are dispatched within 1 business day of payment and sent by Australia Post Express Post with tracking, which usually arrives the next business day across most of the Express Post network (allow a few extra days for regional areas). Express Post is a $15 flat rate, or free on orders of $250 or more. We ship within Australia only. See the shipping policy.
How do I pay?
By PayID or bank transfer. The payment details appear as soon as you place your order and are emailed to you as well. Your order is dispatched once the payment arrives.
Disclaimer
BPC-157 / TB-500 Blend 20mg is supplied for in-vitro and laboratory research only. It is not intended to diagnose, treat, cure or prevent any disease, and is not registered or listed on the Australian Register of Therapeutic Goods. Descriptions on this page summarise published chemical information and do not describe effects in humans or animals.
The purchaser is responsible for safe handling, storage and disposal, and for complying with all laws that apply to them. See the full Disclaimer and Research use terms.
Reviews
There are no reviews yet.